MFI 5000 Series
Protein and antibody characterization
Multiplex protein detection
Gel and blot imaging
Immunoassays and total protein
Protein charge heterogeneity
Protein aggregation and particle analysis
Protein stability and formulation testing
From your peers
Simple Western Ab database
Ways to order
Request info or quote
View news archive
ProteinSimple Says "Never Run a Gel Again!"
ProteinSimple announced today that it has launched a total protein assay for the Simple Western. This new assay allows users to detect all proteins separated in the assay simultaneously. For the first time, Simple Western users can analyze proteins without the need for an antibody.
ProteinSimple Goes Big with the Simple Western
ProteinSimple announced today that it has expanded the Simple Western product platform by launching a kit for the analysis of large proteins using Wes, Sally Sue and Peggy Sue. Now, Simple Western users can analyze proteins as large as 440 kDa while realizing all the benefits of the Simple Western-a fully automated, highly reproducible, truly quantitative assay.
Bio-Techne Announces Agreement to Acquire ProteinSimple
Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that it has agreed to acquire ProteinSimple for $300 million in cash. The closing of the acquisition is subject to the satisfaction of customary closing conditions, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The acquisition is not subject to any financing contingencies. The transaction will be financed through a combination of cash on hand and a new revolving line of credit facility that Bio-Techne expects to obtain prior to the closing of the acquisition.
ProteinSimple Files Registration Statement for Proposed Initial Public Offering
ProteinSimple announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All of the shares to be sold in the proposed offering will be offered by ProteinSimple. The number of shares to be offered and the price range for the offering have not yet been determined.
ProteinSimple Opens Sales Office in Japan
ProteinSimple announced today that it has expanded its global direct distribution capabilities by opening an office in Tokyo, Japan.
ProteinSimple Appoints Joe Keegan and Chris van Ingen to its Board of Directors
ProteinSimple announces the appointments of two independent members of the company's Board of Directors, Mr. Chris van Ingen and Dr. Joe Keegan.
ProteinSimple Launches Second Generation, High Throughput Simple Western Systems
ProteinSimple today launched Sally Sue and Peggy Sue, the next generation of high throughput Simple Western instruments. These instruments drive the sensitivity of the current high throughput Simple Western systems to performance levels well beyond any traditional Western.
ProteinSimple Launches Low-Cost Simple Western
ProteinSimple today introduced Wes, another revolutionary re-invention of the Western blot.
ProteinSimple to Present at the 32nd Annual J.P. Morgan Healthcare Conference
ProteinSimple announced today that Tim Harkness, CEO, will present an overview of the Company at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2014 at 8:00 AM (PST), at the Westin St. Francis Hotel in San Francisco, California.
ProteinSimple Launches Multimode Imager with IR Capability
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
The Simple Western is now cGMP Ready
ProteinSimple today released version 2.4 of Compass Software, which runs its Simple Western instruments complete with CFR Title 21 Part 11 compliance tools. With this software release, not only has ProteinSimple fully redesigned the age-old traditional Western and replaced it with a fully automated, fully quantitative platform, it has now enabled researchers to quickly and easily validate assays run on these systems to meet the standards defined by the FDA.
ProteinSimple to Present at the 33
Annual Cowen and Company Health Care Conference
ProteinSimple, a provider of innovative tools for protein research, announced today that Tim Harkness, CEO, will present an overview of ProteinSimple at the 33
Annual Cowen and Company Health Care Conference on March 4
at 9 AM at the Boston Marriott Copley Place in Boston, Massachusetts.
ProteinSimple to Present at the 31
Annual J.P. Morgan Healthcare Conference
ProteinSimple, focused on providing innovative tools for protein research, announced today that Tim Harkness, CEO, will present an overview of ProteinSimple at the 31
Annual J.P. Morgan Healthcare Conference today at 3:00 PM (PST) at the Westin St. Francis Hotel in San Francisco, California.
ProteinSimple Charges Ahead with the Simple Western
ProteinSimple today introduced Peggy as the next member of the Simple Western product family. Peggy is the first Simple Western product to not only replace the traditional slow, inconsistent Western Blot, but to enable further in-depth characterization of proteins via charge-based separation.
ProteinSimple Reinvents the Western Blot...Again
ProteinSimple today introduced Sally as the next member of the revolutionary Simple Western product family. Sally eliminates a critical bottleneck in large-scale protein research and biopharmaceutical development — manual Western Blot analysis. With Sally, researchers can perform 96 Simple Westerns in a single automated experiment.
ProteinSimple Strengthens Management Team
ProteinSimple today announced that Terry Salyer has joined the team as Vice President of Sales.
ProteinSimple Launches Direct Sales, Service and Support for Biologics Products in Europe
ProteinSimple today initiated direct sales, field service and field applications support throughout Europe for its iCE Imaged Capillary Electrophoresis and MFI Micro-Flow Imaging product families.
ProteinSimple Automates Aggregation Analysis
ProteinSimple today announced the launch of the Bot1 High Throughput Autosampler for its MFI 5000 Micro-Flow Imaging platforms. Bot1 automates analysis of protein aggregates and particles by Micro-Flow imaging. Bot1 will be unveiled at the IBC's 11th Annual Formulation Strategy for Protein Therapeutics conference, November 1-3, 2011, in Long Beach, CA.
ProteinSimple to Offer Direct Sales, Service and Support for Biologics Products in Europe
ProteinSimple today announced plans to provide direct sales, field applications and field service support for its biologics products in Europe, effective January 1, 2012. Two industry-leading product lines are included in this expanded support structure: iCE Imaged Capillary Electrophoresis systems and MFI Micro-Flow Imaging systems.
ProteinSimple Launches New System for Protein Biologics
ProteinSimple today announced the launch of the iCE3, a next-generation platform for quality control monitoring of protein-based therapeutics. The iCE3 platform will be unveiled at the CE Pharm 2011 conference, October 9-13, 2011, at Amelia Island, FL.
ProteinSimple Reinvents the Western Blot
ProteinSimple today introduced a revolutionary new system for protein analysis, Simon and the Simple Western. The Simple Western is a complete reinvention of the Western Blot, and is truly a historic breakthrough for protein research. For the first time in 30 years, researchers have access to a completely automated, walk-away solution for Western analysis.
Cell Biosciences Changes Name to ProteinSimple
Cell Biosciences, Inc. today announced that it has changed its name to ProteinSimple to clearly reflect the Company's core mission in protein research.
Sign up for news releases